Vitro Diagnostics (VODG) 0.0670 $VODG Vitro Biopharma

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vitro Diagnostics (VODG) 0.0670 $VODG

Vitro Biopharma Products Advance Pancreatic Cancer Research
ACCESSWIRE - Tue Mar 11, 9:08AM CDT
Golden, Colorado / ACCESSWIRE / March 11, 2014 / Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced that some of its products are being utilized in advancing pancreatic cancer research including development of new diagnostic tests and new therapeutic approaches. Pancreatic cancer remains one of the most deadly and least survivable cancers; it is asymptomatic until quite advanced and is resistant to conventional therapies. It has recently become apparent that cancer tumor cells are closely associated with other cells called cancer associated fibroblasts or CAFs. These cells promote the malignant process and block immune surveillance. CAFs are thus new drug targets for pancreatic and other cancer therapies. Vitro Biopharma products were used in recent research regarding pancreatic stellate cells, a CAF that is gaining considerable interest for new treatment options through advanced understanding of cancer biology.

10-K: VITRO DIAGNOSTICS INC
Edgar Online - Wed Feb 12, 3:26PM CST
ITEM 7.

Vitro Biopharma Revenues Increase in Early 2014: Plans Trials of Endogenous Stem Cell Activation for Therapeutic Benefit
ACCESSWIRE - Tue Feb 11, 9:19AM CST
Golden, Colorado / February 11, 2013 / ACCESSWIRE / Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced that its revenues increased substantially (78%, unaudited) in its first 2014 fiscal quarter due to its growing and expanding business relationship with Neuromics, Inc. Vitro Biopharma has now commercialized bio-analytical services as the initial stage in its expansion as a Contract Research Organization (CRO). The services now available include select and customized biomarker panel analysis providing customers quantitative levels of multiple biological molecules within various biological samples. The new business involves analysis of human serum samples collected from patients within a network of clinical treatment centers throughout central Europe. Our partner for these services is Joseph Smarta, Ph.D., a renowned immunologist who has orchestrated treatment of many patients suffering from a variety of diseases. While the analyses are for research purposes only, serial analysis of patients are provided to monitor status and indicate therapeutic effectiveness.

Vitro Biopharma's CEO Elaborates on Merger-Driven Growth Acceleration in an Interview with the Wall Street Analyst
ACCESSWIRE - Tue Nov 12, 10:31AM CST
Golden, Colorado - November 12, 2013 - Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced an interview of its CEO by Juan Costello of the Wall Street Analyst (http://thewallstreetanalyzer.com/vitro-diagnostics-otcbbvodg-ceo-interview). In the interview, our CEO elaborated on the effect of its planned merger with Neuromics, Inc. in greater detail and provided an overview of the near-term plans to accelerate growth. Completion of the merger would immediately expand revenues from research products by several-fold. While Vitro Biopharma's research products are primarily focused on adult stem cells and related products, the addition of Neuromics product lines expands our offerings to include antibodies, an expansive number of products for proteomics, apoptosis (cell death) assays, molecular biology reagents, together with numerous cell-based assay products complementary to Vitro's stem cell-based products.

Vitro Biopharma Announces Plans to Acquire and Merge with Neuromics, Inc.
ACCESSWIRE - Tue Oct 15, 1:22PM CDT
Golden, Colorado / October 15, 2013 / ACCESSWIRE / Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, signed a non-binding letter of intent to acquire and merge with Neuromics, Inc, a privately held life-science firm located in Minneapolis, MN. The Merger would be structured as a reverse triangular merger, with Neuromics becoming a wholly-owned subsidiary of Vitro Biopharma. Completion of the proposed merger would reorganize Vitro Biopharma. to include significant expansion in its core product offerings, an improved balance sheet and a novel business model to accelerate growth. Accelerated revenue growth is envisioned through diversified sources including well-established sales to research & clinical development markets, unique stem cell-based assays for use in drug discovery, development and toxicology together with competitive stem cell-based therapies targeting emerging markets in regenerative medicine. The proposed strategic selling approach includes biopharmaceutical firms, large distributors and contract research organizations that would augment the growing and established incremental sales to global research laboratories.

Vitro Biopharma Expands its Product Lines While Targeting New Stem Cell Markets
ACCESSWIRE - Tue Sep 10, 7:00AM CDT
Golden, Colorado - (ACCESSWIRE - September 10, 2013) - Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced expansion of its current product lines and product development in additional market segments including drug discovery & development together with select opportunities within regenerative medicine market sectors. Vitro's present products target markets within stem cell and cancer research. We provide basic research tools including cell lines, cell culture media and assays of cellular function. We have recently added cancer-associated fibroblast cell lines and novel cell culture media formulations broadening our product offerings for research. Cancer-associated fibroblasts (CAFs) are non-tumor cells within cancerous tumors that promote tumor growth and metastasis.

OTC Daily Alert Stock Watch - Vitro Diagnostics, Inc. (OTCQB: VODG)
WorldStockWire - Thu Aug 29, 3:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Vitro Biopharma Appoints Established Life Science Sales Executive to Its Board of Directors
GlobeNewswire - Wed Feb 20, 12:25PM CST
Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, simultaneously accepted the resignation of Mr. Erik Van Horn from its Board of Directors and appointed Pete Shuster, the CEO of Neuromics, Inc. to its Board of Directors. Mr. Shuster is a seasoned and experienced sales executive. He is the current owner of Neuromics, Inc., a privately held and profitable business focused on sales of numerous (> 2500) specialty life science products including stem cell products manufactured by Vitro Biopharma. Neuromics, Inc. sales have grown over 5.5-fold since inception in 2003. Shuster has extensive prior experience in managing sales of computer software and related products for companies including Caterpillar, Baxter Healthcare and Harley-Davidson.

Vitro Biopharma Inc announces commercial availability of MSC-derived human osteoblasts, leading to faster recovery of bone fractures
M2 - Wed Jan 23, 10:44AM CST
Stem cell company Vitro Diagnostics Inc (OTCQB:VODG) said on Tuesday that it has introduced a series of osteoblasts products to accelerate bone growth, fracture healing and development of new osteoporosis drugs.

Vitro Biopharma Launches New Stem Cell Products to Accelerate Bone Growth
GlobeNewswire - Tue Jan 22, 8:51AM CST
Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced the launch of a series of products with application to accelerated bone growth, fracture healing and development of new osteoporosis drugs. The new products are osteoblasts derived from human adult stem cells known as mesenchymal stem cells (MSCs). These cells lead to bone growth and function to maintain bone density and in the recovery from bone fractures. Osteoporosis, a disease characterized by reduction in bone density is thought to result from decreased osteoblast production by MSCs; bone growth necessary for repair of bone fractures also depends on osteoblasts. The new products include native and labeled MSC-derived human osteoblasts in various formats including fluorescent and magnetic cells for use in different imaging methods. For example, magnetic osteoblast cells labeled with super paramagnetic iron oxide (SPIO) may be used for in-vivo imaging of osteoblasts using magnetic resonance imaging (MRI) a common clinical imaging proced
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HVAC’s $383.6 Billion Shift Is About More Than Units

Updated Category News Views 101

Server racks are turning cooling gear into a front-row industrial story, and that deserves more attention than the usual sleepy talk about replacement air conditioners. Frost & Sullivan projects the global HVAC equipment market will reach $383.6 billion by 2031, growing at a 7.0% compound annual rate from 2025. That is a sizable market, sure, but the more interesting...

Continue Reading
Northgate’s Stanton Opening Puts Community Work First

Updated Category News Views 0

A 55,721-square-foot grocery opening can look like ordinary retail churn until you notice where the money and attention are landing. Northgate González Market’s new Stanton location arrives ahead of Thanksgiving, yes, but the more telling detail is the company’s decision to pair a major store launch with 375 jobs and more than $30,000 directed toward families,...

Continue Reading
Travel Awards Spotlight Luxury Hospitality's Reach

Updated Category News Views 39

Hong Kong’s awards roll call reads less like a scorecard than a map of where premium travel wants its money and attention to go next. The 2026 World’s Travel & Hotel Awards, released November 20, cast a very wide net: heritage palaces, city hotels, beach retreats, airlines, cruise operators, tourism boards, restaurants, serviced apartments and a fair number of...

Continue Reading
Zensar’s AI Forum Puts Operations Before the AI Hype

Updated Category News Views 111

Johannesburg’s AI conversation seems to be shedding its costume jewelry at last. Zensar’s invitation-only CIS Converge 2026 forum, held on November 20, put the attention where it belongs: not on breathless demos, but on whether companies can turn AI into sturdier operations, better customer experiences, and something resembling a measurable return. That is a healthier...

Continue Reading
CITGO Sign Return Caps Kenmore's Careful Rebuild Work

Updated Category News Views 25

Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...

Continue Reading
IAS Marks 42 Years Amid Germany Religious Freedom Win

Updated Category News Views 96

Bagpipes, country roads and a gathering from six continents made this far more than a routine anniversary reception. The International Association of Scientologists marked its 42nd anniversary at Saint Hill in East Grinstead, England, with thousands of Scientologists and guests arriving as autumn settled over West Sussex. That sort of turnout is a visible statement of...

Continue Reading
Morrison Tests Abu Dhabi as Its Next Capital Hub

Updated Category News Views 41

Abu Dhabi keeps collecting infrastructure managers the way a strong port collects ships: because the money, the policy ambition, and the projects are all converging there. Morrison’s decision to establish an office in ADGM is not some chest-thumping headline about instant deal flow. It is a practical move by a firm with nearly four decades behind it and more than US$35...

Continue Reading
Clickstop's Urbana Expansion Bets on Durable Demand

Updated Category News Views 126

A patch of turned Iowa dirt can say plenty about a company’s nerve. Clickstop broke ground in Urbana on Nov. 19, 2026, for a 43,000-square-foot building, and the message is pretty plain: management believes its recent growth has legs. For a privately held, employee-owned operator serving trucking, construction, lifting and rigging, that is not a casual decision....

Continue Reading
Stowers Brings a Transformation CTO Into Its Lab

Updated Category News Views 125

Data Has Become Lab Infrastructure Microscopes may get the glory, but the plumbing behind modern biology is increasingly digital, sprawling and unforgiving. That is why Stowers Institute for Medical Research appointing Brandon Mayer as vice president and chief technology officer on November 19, 2026, deserves more attention than the usual executive-shuffle treatment. This...

Continue Reading
Rosenblatt Book Puts Vegas Casino Blind Spots on Display

Updated Category News Views 143

A locked casino floor is supposed to make secrets expensive. That is why the pitch behind ROSENBLATT lands with a little more weight than the usual Vegas chest-thumping: the coming memoir says Darryl Rosenblatt became a million-dollar gambler while using none of his own money, and that casino operators did not grasp the full shape of what had happened for years. Take a...

Continue Reading

Top 5 Most Recently Viewed Articles

Novartis Faces Setback as Entresto Generic Approved

Updated Category News Views 393

Novartis' Legal Challenges with Entresto Generic Novartis, a leading pharmaceutical company, recently encountered a significant setback in its attempts to block the launch of a generic version of its heart-failure medication, Entresto. A federal judge in Washington, D.C., ruled against Novartis', effectively paving the way for MSN Pharmaceuticals to release its generic...

Continue Reading
Walk-On's Partners with Port Royal for Expansive Growth

Updated Category News Views 581

Walk-On's Sports Bistreaux Announces Major Development Deal Walk-On's Sports Bistreaux is thrilled to announce a pivotal partnership with Port Royal Brands, marking a significant step forward in its expansion plans. This exciting collaboration will encompass the development of 20 new restaurants, aiming to bring the spirit of family-friendly sports dining to new...

Continue Reading
Gabelli Healthcare & Wellness Trust Announces Quarterly $0.17 Distribution

Updated Category News Views 152

Gabelli Healthcare & Wellness Trust Declares Cash Distribution The Board of Trustees of The Gabelli Healthcare & Wellness Trust (NYSE: GRX) has announced a cash distribution of $0.17 per share. This distribution is set to be paid to common shareholders on a specified date. The Board's decision reflects ongoing efforts to provide regular income to investors. Distribution...

Continue Reading
Faraday Future Prepares for Third Quarter Earnings Call

Updated Category News Views 119

Faraday Future Announces Earnings Conference Call Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) is excited to share the timeline for its scheduled earnings conference call focused on its third quarter results for 2024. This highly anticipated call will occur after market hours, specifically on a Wednesday evening, at 5:00 p.m. Pacific Time. Investors and...

Continue Reading
Chicagoland Leaders Rally to Support Local Black Businesses

Updated Category News Views 123

Community Leaders Unite for Local Black Businesses In a powerful display of solidarity, community leaders and clergy in Chicagoland are calling on the City Council to take decisive action in support of local Black-owned businesses. One business at the heart of this effort is Island Furs, a beloved fixture that has proudly served the community for over 30 years. The...

Continue Reading